The United Laboratories International Holdings Limited (HKG:3933)

HKG:3933 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,330	4,262	4,743	3,331	2,997
Cash & Short-Term Investments	6,330	4,262	4,743	3,331	2,997
Cash Growth	48.52%	-10.14%	42.39%	11.15%	-5.31%
Accounts Receivable	5,726	5,863	4,476	3,424	2,953
Other Receivables	546.36	451.76	435.88	376.25	406.66
Receivables	6,272	6,314	4,912	3,800	3,359
Inventory	2,434	2,238	2,164	2,004	1,429
Other Current Assets	1,034	972.25	696.55	851.39	440.19
Total Current Assets	16,071	13,787	12,515	9,986	8,225
Property, Plant & Equipment	9,175	6,874	6,188	6,069	6,373
Long-Term Investments	7.11	7.8	7.66	0.5	0.5
Goodwill	3.03	3.03	3.03	3.03	3.03
Other Intangible Assets	209.2	1.71	3.41	5.24	8.16
Long-Term Deferred Tax Assets	73.68	80.8	80.03	82.78	78.25
Long-Term Deferred Charges	-	132.25	96.93	114.58	123.12
Other Long-Term Assets	294.01	130.28	85.74	69.18	152.72
Total Assets	25,833	21,017	18,980	16,331	14,964
Accounts Payable	4,175	4,220	3,558	3,211	2,277
Accrued Expenses	1,100	782.08	797.29	672.55	539.95
Short-Term Debt	-	23.85	251.38	18.35	26.49
Current Portion of Long-Term Debt	830.38	174	1,108	1,597	880.65
Current Portion of Leases	4.78	2.51	3.74	3.87	1.69
Current Income Taxes Payable	204.35	232.55	209.48	108.09	180.2
Current Unearned Revenue	132.61	156.93	184.93	164.03	135.38
Other Current Liabilities	2,325	1,035	919.8	760.31	818.01
Total Current Liabilities	8,773	6,627	7,033	6,535	4,860
Long-Term Debt	2,308	1,299	1,096	221.21	1,307
Long-Term Leases	12.67	4.32	3.9	7.13	-
Long-Term Unearned Revenue	22.21	32.24	43.41	55.32	65.35
Long-Term Deferred Tax Liabilities	282.49	288.08	194.07	172.31	119.58
Other Long-Term Liabilities	-	19.19	-	-	-
Total Liabilities	11,398	8,270	8,370	6,991	6,352
Common Stock	16.97	16.97	16.97	17.13	17.18
Additional Paid-In Capital	-	3,722	3,722	3,782	3,806
Retained Earnings	-	7,283	5,328	5,274	4,507
Treasury Stock	-	-	-	-17.82	-
Comprehensive Income & Other	14,371	1,712	1,540	284.78	284.31
Total Common Equity	14,388	12,735	10,608	9,340	8,614
Minority Interest	46.96	12.84	1.35	-0.58	-2.07
Shareholders' Equity	14,435	12,748	10,609	9,340	8,612
Total Liabilities & Equity	25,833	21,017	18,980	16,331	14,964
Total Debt	3,156	1,504	2,463	1,848	2,216
Net Cash (Debt)	3,174	2,758	2,280	1,483	780.89
Net Cash Growth	15.07%	20.96%	53.75%	89.92%	-
Net Cash Per Share	1.75	1.52	1.25	0.81	0.44
Filing Date Shares Outstanding	1,817	1,817	1,817	1,829	1,840
Total Common Shares Outstanding	1,817	1,817	1,817	1,829	1,840
Working Capital	7,298	7,160	5,482	3,451	3,365
Book Value Per Share	7.92	7.01	5.84	5.11	4.68
Tangible Book Value	14,176	12,730	10,602	9,332	8,603
Tangible Book Value Per Share	7.80	7.01	5.83	5.10	4.67
Land	-	4,917	4,543	4,458	4,402
Machinery	-	8,417	8,103	7,873	7,688
Construction In Progress	-	413.51	264.2	120.65	137.16

Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.